PROM1 and hepatocellular carcinoma: Additionally, circulating ECVs in HCC display altered expression of surface markers, including Annexin V, EpCAM, ASGR1, and CD133, offering a panel of markers to distinguish HCC from cholangiocarcinoma and other malignancies [107,108].